QCM Cayman’s Cardinal Health CAH Stock Holding History

QCM Cayman’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,881	Closed	-$398K	–	186
2017 Q1	$398K	Buy	+4,881	New	+$384K	0.07%	230

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

QCM Cayman's CAH Position: Q2 2017 in Review

QCM Cayman sold out of Cardinal Health (CAH) in Q2 2017, closing a stake of 4,881 shares — an estimated $398K sold.

QCM Cayman first reported a position in CAH in Q1 2017 and held it in 1 quarter. The position peaked at $398K in Q1 2017. 747 funds tracked by Wall St. Rank hold CAH as of Q2 2017.

QCM Cayman reported no remaining Cardinal Health position as of Q2 2017 after selling out during the quarter.
QCM Cayman sold 4,881 Cardinal Health shares in Q2 2017, an estimated $398K.
QCM Cayman first reported a position in Cardinal Health in Q1 2017 and held it in 1 quarter.
QCM Cayman's Cardinal Health position peaked at $398K in Q1 2017.
747 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2017.

Based on QCM Cayman's 13F filing for Q2 2017, filed 14 Aug 2017.